Thymotrinan (TFA)

• Description :

  Thymotrinan (RGH-0205) TFA is a biologically active fragment of the naturally occurring thymus hormone thymopoietin and a immunomodulating peptide. Thymotrinan TFA exerts similar immunomodulatory activities to TP5 and to affect humoral as well as cellular responses[1].

• Product Name Alternative :

  RGH-0205 (TFA) ; TP3 (TFA)

• UNSPSC :

  12352209

• Target :

  Others

• Type :

  Reference compound

• Related Pathways :

  Others

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/thymotrinan-tfa.html

• Purity :

  98.66

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(O)C(F)(F)F.OC(C[C@@H](C(O)=O)NC([C@H](CCCCN)NC([C@@H](N)CCCNC(N)=N)=O)=O)=O

• Molecular Formula :

  C18H32F3N7O8

• Molecular Weight :

  531.48

• References & Citations :

  [1]Heizmann J, et al. Enzymatic cleavage of thymopoietin oligopeptides by pancreatic and intestinal brush-border enzymes. Peptides. 1996;17 (7) :1083-1089.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported